Octaplas Solution
Product Images NDC 68982-955

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Octaplas (NDC 68982-955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Octapharma Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image File (Img0001)

A data table showing virus reduction factors in log10 for HIV-1, PRV, SBV, and BVDV in the production process of Octaplas. It compares the S/D treatment step and the global reduction factor, indicating virus reduction values equal to or greater than specific log10 thresholds for each virus.*

FDA Label Image

Image File (Img0002)

Label for Octaplas pooled plasma (human), solvent/detergent treated solution, 11.5 g/200 mL, for intravenous use. The label includes human plasma protein content, storage instructions, blood group 0 designation, lot and expiration date placeholders, and manufacturer Octapharma USA Inc information with multiple barcodes present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.